Appeal No. 2006-3204 Page 5 Application No. 10/057,629 Appellant cites Hidaka,4 Nguyen5 and Salen,6 all of which teach that HMG-CoA reductase inhibitors such as lovastatin and pravastatin are ineffective in the treatment of sitosterolemia. Thus, Hidaka teaches that “[p]ravastatin had little effect in a sitosterolemic patient on plasma levels of sterols, where cholestyramine decreased the plasma levels of both cholesterol and cholestanol.” Hidaka, abstract. Salen teaches that “[l]ovastatin, a competitive inhibitor of cholesterol biosynthesis that is widely used in the treatment of hypercholesterolemia has been tried but has not been an effective treatment in sitosterolemia.” Salen, page 952, paragraph bridging the two columns. Nguyen also teaches that lovastatin is “ineffective” in the treatment in sitosterolemia. Nguyen, page 1942, first column. Moreover, Nguyen suggests that differences in responses may be used diagnostically. Specifically, Nguyen teaches that “[t]he therapies with cholestyramine and lovastatin not only support our contention of the fundamental abnormality in the regulation of cholesterol biosynthesis that underlies sitosterolemia, but the response to these therapies can also be used to detect sitosterolemia. . . . Therefore, the failure to respond to lovastatin and a substantial response to cholestyramine may suggest sitosterolemia . . . .” Id. at page 1946, second column. 4 Hidaka et al. (Hidaka), “Effects of an HMG-CoA Reductase Inhibitor, Prevastatin, and Bile Sequestering Resin, Cholestyramine, on Plasma Plant Sterol Levels in Hypercholesterolemic Subjects,” Journal of Atherosclerosis and Thrombosis, Vol. 2, No. 1, pp. 60-65 (1995). 5 Nguyen et al. (Nguyen), “Regulation of cholesterol biosynthesis in sitosterolemia: effects of lovastatin, cholestyramine, and dietary sterol restriction,” Journal of Lipid Research, Vol. 32, pp. 1941-48 (1991). 6 Salen et al. (Salen), “Sitosterolemia,” Journal of Lipid Research, Vol. 33, pp. 945-55 (1992).Page: Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Next
Last modified: September 9, 2013